Skip to main content

ETS Logo European Teratology Society

Home
European Teratology Society - ETS
  • About us
  • Membership
  • Meetings
  • News
  • Links
  • Sponsors
  • ETS DART Course 2021
  • ETS DART Course 2021: Downloads
  • Annual Meeting
  • Meeting Registration

ETS DART Course 2021

 

REGISTRATION IS NOW OPEN

Click here for more information

ETS Membership

If you would like information on membership please click on the button below

learn more

Members Area

If you are a registered ETS member you can access the member area by clicking on the button below

learn more

49th annual meeting

Madrid, Spain • 20th to 23rd September 2021

Click here for more information

Previous Next

Status of the ETS Annual Meeting

Due to the current COVID-19 Situation this years ETS meeting will be hold as a one-day virtual meeting with a keynote lecture, one symposium, and some flash talks. An ETS/BDRP debate will also be part of our virtual programme. September 15th 2020 has been tentatively blocked for this virtual meeting, therefore please save the date in your agendas. Click here for more information and registration (available August 5th 2020).

Our meeting in Madrid (Spain) has been postponed until September 20th to 23rd 2021. We hope to see you all there!

Thank you very much for your patience and for supporting our society,

Arantza Muriana, organizer of the 2020 ETS meeting

Welcome to the ETS website

ETS DART Course 2021

Published: 11 June 2020
11 June 2020
Category: News
News

REGISTRATION IS NOW AVAILABLE

Course Topics

  • Male and Female Reproductive Physiology
  • Early embryonic development
  • Cellular and Molecular processes in early development
  • Cardiovascular development
  • Gastrointestinal development
  • Respiratory development
  • Neurobehavioural development
  • Craniofacial development
  • Fertility testing
  • Developmental toxicity testing
  • PPND and juvenile toxicity testing
  • PK/ADME during pregnancy/lactation
  • Risk assessment Endocrine disruption
  • New approaches and methodologies

Biosketches

  • Alan Hoberman
  • Aldert Piersma
  • Arantza Muriana
  • Didima M G de Groot
  • Emily Richmond
  • Geertje Lewin
  • Graham Bailey
  • John M. Tesh
  • Luc De Schaepdrijver
  • Manon Beekhuijzen
  • Paul Barrow
  • Peter Bols
  • Pieter Annaert
  • Sheila A. Tesh
  • Steven Van Cruchten

ETS 2021 DART course

Last Updated: 13 January 2021
13 January 2021

Webinar: Surveillance and Prevalence Estimation of Neural Tube Defects, May 19, 11 AM ET

Published: 30 April 2020
30 April 2020
Category: News
News

Abstract:

In November 2018, the Society for Birth Defects Research and Prevention published a position statement on surveillance and prevalence estimation of neural tube defects. This position statement was co-authored by Vijaya Kancherla, Susan L Carmichael, Marcia L Feldkamp, and Robert J Berry, and was endorsed by the organizations co-sponsoring this webinar.

In the position statement, the Society for Birth Defects Research and Prevention, then known as the Teratology Society, acknowledges the value of accurate measurement of total prevalence of neural tube defects (NTDs) in the population to support prevention, and advocates for rigorous surveillance worldwide. Birth defects surveillance is fundamental to understanding NTD prevalence, and an essential aspect of prevention efforts. Active, multi-source, population-based birth defects surveillance with standard data collection protocols is vital to assess baseline NTD prevalence for an effective implementation of folic acid intervention in countries, and to evaluate its global impact. The choice of pregnancy outcomes included in the numerator and denominator of the prevalence formula significantly influences the estimated burden of NTDs in the population. Methodologic approaches in prevalence estimation have differed across countries, with different pregnancy outcomes (i.e., live births, stillbirths, and elective terminations for fetal anomalies) used in the numerator and denominator of the prevalence formula. The Society recommends the following approaches for standardizing and improving NTD prevalence estimation globally: 1) Prevalence estimates should be based on population-based surveillance that utilizes multiple data sources and standard data collection protocols to include all pregnancy outcomes and infant mortality; and 2) Prevalence estimates should capture all NTD phenotypes and include anencephaly and NTDs that co-occur with other major birth defects or syndromes. The Society acknowledges that inaccuracies in surveillance findings have a potential to hinder prevention and should be addressed and corrected as soon as possible. The society will continue to champion for improved NTD prevalence estimation procedures and standardizing them globally.

In this webinar, Dr. Kancherla will discuss the position statement as well as her current relevant research.

Speaker Biography:

Dr. Vijaya Kancherla is a Research Assistant Professor in the Department of Epidemiology at Emory University Rollins School of Public Health. She also works as an epidemiologist at the Center for Spina Bifida Prevention at Emory University. Dr. Kancherla has received her doctoral degree in Epidemiology from the University of Iowa, and completed post-doctoral training as Pierre Decouflé Fellow with the National Center on Birth Defects and Developmental Disabilities (NCBDDD) at the US Centers for Disease Control and Prevention (CDC). Her current work includes neural tube defects surveillance, risk factors and health outcomes research, prevention, and policy. She serves on various research national and international committees examining neural tube defects epidemiology and global prevention strategies for these birth defects. She is an affiliate member of the International Clearinghouse on Birth Defects Surveillance and Research (ICBDSR), member of the Public Affairs Committee of the Society for Birth Defects Research and Prevention (BDRP), and a consultant to the to the WHO Department of Maternal, Newborn, Child and Adolescent Health and the Nutrition International’s Folate Task Team.

Webinar recording Link: https://youtu.be/h8MR4EziXxg

 

Last Updated: 11 June 2020
11 June 2020

49th annual meeting, 2021, Madrid, Spain

Published: 12 December 2019
12 December 2019
Category: Annual ETS Meetings
Annual ETS Meetings

Madrid will be the venue for the 49th Annual Meeting of the European Teratology Society, which will be held on Monday 20th to Thursday 23rd September 2021.

Read more ...

Last Updated: 04 August 2020
04 August 2020
Janssen Pharmaceutica
PreClinical Safety (PCS) Consultants Ltd.
Pfizer: One of the world's premier biopharmaceutical companies
Sanofi - A global healthcare leader focused on patients' needs
Roche - Doing now what patients need next

Membership

Interested in becoming an ETS member? Click here for more information.

Members Area

Already an ETS member? Click here to access the members area.

Registration

ETS member without a website account? Click here to register.

ETS Treasurer

Steffen Schneider
BASF 
treasurer@etsoc.com

ETS Secretary

Stephanie Clubb
Charles River
secretary@etsoc.com

ETS Webmaster

Jason Manton
Penman Consulting Ltd
webmaster@etsoc.com

Congress organization

Solution office e.K.
Kay Groothoff
Bergstr. 2, 29646 Bispingen, Germany
P: +49 5194 97449-0
F: +49 5194 97449-4
This email address is being protected from spambots. You need JavaScript enabled to view it.
© 2021 European Teratology Society
  • Terms of Service
Back to Top